Compare Dicks Sporting Goods Inc (DKS) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dicks Sporting Goods Inc vs BIO-TECHNE Corp — how do they compare? Dicks Sporting Goods Inc trades at $134.34 (market cap $12.92B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: Dicks Sporting Goods Inc and BIO-TECHNE Corp are close in size by market cap, and Dicks Sporting Goods Inc pays the higher dividend (3.81%). Which is the better fit depends on your goals — on Pluang, investors hold Dicks Sporting Goods Inc for 19 Days and BIO-TECHNE Corp for 63 Days on average.
| DKS | TECH | |
|---|---|---|
Market Cap | $12.92B | $11.37B |
Volume | 2,077,432 | 3,153,511 |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $72.61 |
52-Week Low | $121.15 | $43.31 |
Typical Hold Time | 19 Days | 63 Days |
Enterprise Value | $19.97B | $11.40B |
Dividend Yield | 3.81% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $131.18, down 2.74% on the day, with a bearish technical signal from moving averages and oscillators. The company shows solid profitability with an 18.47% ROE and a net income margin of 3.97%, though recent earnings missed expectations in Q2 2026. Revenue grew to $13.44B in 2025, but profit margins are projected to compress in 2026. A securities class action lawsuit filed for the period September 2025 to August 2026 adds legal overhang.
The stock presents a mixed outlook; strong analyst consensus with a $153.30 price target suggests 17% upside, supported by a reasonable P/E of 14.48. However, near-term risks include the class action litigation, technical bearishness, and margin pressure. The dividend increase to $1.25 signals confidence, but investors must weigh legal and operational headwinds against valuation appeal.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
